Mapping the EQ-5D index from the cystic fibrosis questionnaire-revised using multiple modelling approaches

Mapping to Obtain EQ-5D Utility Values for Use in NICE Health Technology Assessments

(2013) Louise Longworth et al.   VALUE IN HEALTH

Mapping for economic evaluation

(2012) L.-H. Chuang et al.   BRITISH MEDICAL BULLETIN

Quality of life and healthcare utilisation in cystic fibrosis: a multicentre study

(2012) Judy M. Bradley et al.   EUROPEAN RESPIRATORY JOURNAL

Erratum to: Psychometric evaluation of the Cystic Fibrosis Questionnaire-Revised in a national, US sample

(2012) Alexandra L. Quittner et al.   QUALITY OF LIFE RESEARCH

Managing Cystic Fibrosis

(2011) Malena Cohen-Cymberknoh et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Health-related quality of life in cystic fibrosis

(2011) Frederick H. Royce et al.   CURRENT OPINION IN PEDIATRICS

Mapping onto Eq-5 D for patients in poor health

(2010) Matthijs M Versteegh et al.   Health and Quality of Life Outcomes

Pulmonary exacerbations are associated with subsequent FEV1 decline in both adults and children with cystic fibrosis

(2010) Don B. Sanders et al.   PEDIATRIC PULMONOLOGY

Mapping SF-36 onto the EQ-5D index: how reliable is the relationship?

(2009) Donna Rowen et al.   Health and Quality of Life Outcomes

Converting the SF-12 into the EQ-5D

(2009) Ling-Hsiang Chuang et al.   PHARMACOECONOMICS

Mapping analyses to estimate health utilities based on responses to the OM8-30 otitis media questionnaire

(2009) Helen Dakin et al.   QUALITY OF LIFE RESEARCH

Deriving an Algorithm to Convert the Eight Mean SF-36 Dimension Scores into a Mean EQ-5D Preference-Based Score from Published Studies (Where Patient Level Data Are Not Available)

(2008) Roberta Ara et al.   VALUE IN HEALTH

Mapping Utility Scores from a Disease-Specific Quality-of-Life Measure in Bariatric Surgery Patients

(2008) Stefan Sauerland et al.   VALUE IN HEALTH